Bharat Parenterals Ltd reported an increase in revenues and EBITDA for the FY 24, and expects further growth in FY 25, focusing on R&D and talent investment.
AI Assistant
Bharat Parenterals Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.